A BRIEF REVIEW ON ROLE OF COMPUTER AIDED DRUG DESIGN IN THE DEVELOPMENT OF VITAL TYROSINE KINASE INHIBITOR COMPOUNDS
Computer-aided drug design has developed as a prevailing technique playing a vital role in the progress of new drug molecules over the past couple of decades. There are certain drugs which was designed, optimized, synthesized, patented and marketed by the application of computer aided drug designing. This review focussed on the reputation of computer aided drug design in the development of vital tyrosine kinase inhibitor compounds for the treatment of different type of cancers. Drugs with Tyrosine kinase inhibitory activity involves Receptor Tyrosine Kinase Inhibitors (RTK inhibitors), Non-Receptor Tyrosine Kinase Inhibitors (NRTK inhibiotors), and Multi-targeted Tyrosine Kinase Inhibitors. (1) Key Words: Computer Aided Drug Design, Receptor Tyrosine Kinase Inhibitors, VEGFR
Authors
- Manju M. Nair
- SEBA M C
- TINU B SHAJI
- NEETHU M S
- ANOOPA JOHN
- KRISHNA M S
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24317032
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00